Protect Your Investment: Contact Levi & Korsinsky About the Evolent Health, Inc. (EVH) Investigation

New York, New York--(Newsfile Corp. - August 8, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Evolent Health, Inc. ("Evolent Health, Inc.") (NYSE: EVH) concerning possible violations of federal securities laws.

On August 8, 2025, Evolent issued a press release announcing second quarter revenue results that were below analysts' expectations. Management lowered its full-year revenue guidance attributing it to volatility in the managed care industry.

Following this news, Evolent's stock price fell by $1.30 per share to open at $8.39 per share. To obtain additional information, go to:

https://zlk.com/pslra-1/evolent-health-inc-lawsuit-submission-form?prid=160575&wire=5&utm_campaign=68

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212)363-7500.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261902